NR3C1 and diabetes mellitus: Activation of GR target gene activity in the gluconeogenesis pathway in the liver is a key mechanism in the development of hyperglycemia, an established adverse effect of exogenous glucocorticoid treatment that can lead to diabetes mellitus (Li and Cummins, 2022).